Sung Lee | Gilead Sciences, Inc. |
Robin L. Washington | Gilead Sciences, Inc. |
Laura Hamill | Gilead Sciences, Inc. |
John G. McHutchison, AO, MD | Gilead Sciences, Inc. |
John F. Milligan, PhD | Gilead Sciences, Inc. |
Geoff Meacham | Barclays Capital, Inc. |
Brian Abrahams | RBC Capital Markets LLC |
Michael J. Yee | Jefferies LLC |
Matthew K. Harrison | Morgan Stanley & Co. LLC |
Geoffrey C. Porges | Leerink Partners LLC |
Greg Harrison | Citigroup Global Markets, Inc. |
Umer Raffat | Evercore Group LLC |
Alethia Young | Cantor Fitzgerald |
Phil Nadeau | Cowen & Co. LLC |
Cory W. Kasimov | JPMorgan Securities LLC |
Terence Flynn | Goldman Sachs & Co. LLC |
Ying Huang | Bank of America Merrill Lynch |
Steven Seedhouse | Raymond James & Associates, Inc. |
Ladies and gentlemen, thank you for standing by, and welcome to the Gilead Sciences Third Quarter 2018 Earnings Conference Call. My name is Cherie, and I will be your conference operator today. At this time, all participants are in a listen-only mode, and as a reminder, this conference call is being recorded. I would now like to turn the call over to Sung Lee, Vice President of Investor Relations. Please go ahead.